4.1
신체 내 약물 분포는 약물이 다양한 구획을 가로질러 두 방향으로 이동하는 역동적인 과정입니다. 혈류에서 조직으로(조직 흡수) 그리고 조직에서 혈류로(조직 방출 또는 재분배) 이동합니다. 이 과정은 수동적이며 주로 두 가지 변수에 의해 주도됩니다. 혈류와 혈관 외 조직…
분포는 신체 내의 서로 다른 구획 사이에서 약물의 양방향 이동을 나타냅니다.
이는 혈액과 혈관 외 조직 사이의 농도 구배에 의해 주도되는 수동적 과정입니다.
처음에는 혈액 내 유리 약물이 모세혈관 벽을 빠르게 투과하여 세포외액(ECF)으로 들어갑니다.
거기에서 조직 세포막을 가로질러 세포 내 액체에 도달합니다.
이 단계는 속도 제한 단계이며 두 가지 주요 요인에 의존합니다. 첫 번째는 약물이 조직에 얼마나 빨리 전달되는지를 결정하는 세포 외 조직으로의 관류 속도입니다.
두 번째는 약물의 막 투과성입니다. 그것은 약물이 얼마나 쉽게 세포막을 통과할 수 있는지를 지시합니다.
약물 유통에 영향을 미치는 다른 요인으로는 장기 또는 조직 크기, 생리적 장벽 및 개인이 있습니다.
약물이 분배되는 체액의 이론적 부피는 분포의 부피로 설명됩니다.
View the full transcript and gain access to JoVE Core videos
Q1: What is drug distribution and how does it work in the body?
Drug distribution is the two-way movement of a drug between different body compartments, driven by concentration gradients. Free drug in the blood passively permeates capillary walls and enters the extracellular fluid. From there, it crosses cell membranes to reach intracellular fluid. This process is passive and relies on the concentration difference between blood and tissues to move drugs throughout the body.
Q2: Why is crossing the cell membrane the rate-limiting step in drug distribution?
Crossing the cell membrane is the rate-limiting step because it determines how quickly a drug reaches its site of action inside cells. Two factors control this step: perfusion rate, which determines how fast the drug reaches tissue, and membrane permeability, which dictates how easily the drug crosses the cell membrane. Together, these factors govern the overall speed of drug distribution throughout the body.
Q3: How does plasma protein binding affect drug distribution?
Drugs bound to plasma proteins like albumin become inactive and cannot cross cell membranes, limiting their availability for tissue uptake. Only free, unbound drug can distribute into tissues. This binding significantly restricts how much active drug reaches target cells, making protein binding a critical factor in determining drug distribution patterns and therapeutic effectiveness.
Q4: What role do physiological barriers play in drug distribution?
Physiological barriers like the blood-brain barrier restrict passage of certain substances, protecting sensitive organs such as the brain. These barriers limit which drugs can reach specific tissues, affecting overall distribution patterns. Individual differences in barrier function and drug characteristics determine whether a drug can cross these protective boundaries to reach its target tissue.
Q5: How does tissue release occur after drug distribution?
Tissue release occurs when drug concentrations in the bloodstream decrease due to metabolism or elimination, creating a reverse concentration gradient. Drugs diffuse back from tissues into the blood, driven by this concentration difference. The tissue's affinity for the drug, presence of binding proteins, and the drug's ability to diffuse through membranes all influence the rate of tissue release.
Q6: What factors besides perfusion and permeability influence drug distribution?
Organ or tissue size impacts how much drug can be accommodated, while individual differences such as genetic variations, metabolism rates, and overall health influence distribution patterns. These factors work alongside perfusion rate and membrane permeability to determine the final distribution of a drug throughout the body and its therapeutic effectiveness.
Q7: What does volume of distribution represent in pharmacokinetics?
Volume of distribution is a hypothetical volume representing the body fluid space where a drug disperses to achieve the observed blood concentration. It quantifies the extent of drug distribution within the body and helps predict how widely a drug spreads. A larger volume of distribution indicates the drug distributes extensively into tissues, while a smaller volume suggests limited tissue penetration.